Durante W, Sunahara F A, Sen A K
Department of Pharmacology, University of Toronto, Ontario, Canada.
Cardiovasc Res. 1989 Jan;23(1):40-5. doi: 10.1093/cvr/23.1.40.
There is increasing evidence that patients with diabetes mellitus are prone to ischaemic heart disease. This study examined cardiac hyperactivity and its consequent metabolically induced coronary dilatation in isolated, perfused, electrically paced rat hearts from control and spontaneously diabetic Bio-Breeding (BB) rats. Cardiostimulation produced by noradrenaline, calcium, or by tachycardia elicited increases in coronary flow that were significantly lower in diabetic hearts. However, the inotropic responses to noradrenaline and calcium in diabetic preparations were comparable to control. When coronary vascular reactivity was tested with sodium nitroprusside and adenosine, a decreased dilator response was observed with adenosine in diabetic hearts while no difference was observed with sodium nitroprusside. It is suggested that failure in the adaptive coronary flow response to cardiac hyperactivity in diabetes may, in part, be responsible for the higher incidence of ischaemic heart disease in the diabetic population.
越来越多的证据表明,糖尿病患者易患缺血性心脏病。本研究检测了对照大鼠和自发性糖尿病生物繁殖(BB)大鼠离体、灌注、电起搏心脏的心脏活动亢进及其随之而来的代谢诱导性冠状动脉扩张。去甲肾上腺素、钙或心动过速引起的心脏刺激会使冠状动脉血流量增加,而糖尿病心脏中的增加幅度明显较低。然而,糖尿病制剂对去甲肾上腺素和钙的变力反应与对照相当。当用硝普钠和腺苷测试冠状动脉血管反应性时,糖尿病心脏中腺苷引起的扩张反应降低,而硝普钠则未观察到差异。有人认为,糖尿病患者对心脏活动亢进的适应性冠状动脉血流反应失败可能部分导致了糖尿病患者缺血性心脏病的发病率较高。